AbCellera Biologics Inc.

An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.

ABCL | NDAQ

Overview

Corporate Details

ISIN(s):: CA00288U1066
LEI:
Country:: United States of America
Address:: 150 W 4TH AVENUE, VANCOUVER
Website:: https://www.abcellera.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, AI-powered drug discovery platform that integrates advanced technologies in biology, computation, and engineering. This full-stack platform is designed to search, decode, and analyze natural immune systems at high speed and scale to find novel antibodies for therapeutic development. AbCellera partners with pharmaceutical and biotech companies to advance a pipeline of first-in-class and best-in-class antibody programs across various therapeutic areas, including cancer and endocrinology. The platform supports the development of complex modalities, such as bispecifics and antibody-drug conjugates, for conditions with high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbCellera Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbCellera Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AbCellera Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CreoSG Co.,Ltd. Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.	South Korea	040350
CRG HOLDINGS CO.,LTD. Provides IT-driven HR services, outsourcing, system solutions, and financial advisory.	Japan	7041
CRONEX.CO.,LTD CRO supplying mini-pigs and bio-tissues for non-clinical R&D in medical and cosmetic industries.	South Korea	215570
Cross Marketing Group Inc. Delivers marketing insights via research and digital solutions using a large Japanese consumer panel.	Japan	3675
CrowdWorks Inc. Japan's largest crowdsourcing service with HR solutions and SaaS to connect companies and talent.	Japan	3900
C&R Research Inc. Leading South Korean CRO offering end-to-end clinical trial services for life science companies.	South Korea	359090
CRYO CELL INTERNATIONAL INC Cryopreserves newborn cord blood and tissue stem cells for expectant families.	United States of America	CCEL
Curasight A/S Developing uPAR theranostics to precisely diagnose and treat cancers like brain and prostate.	Denmark	CURAS
Cyclezyme AB Develops enzymatic solutions for recycling plastic waste into new raw materials.	Sweden	CYCLE
Dark Star Minerals Inc. Exploring for uranium & REEs, critical minerals for the clean energy and tech sectors.	Canada	BATT